Skip to main content
    C

    Cocrystal Pharma Inc (COCP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.98
    -0.00 (-0.24%)

    Market Cap: $18.88M

    Last updated: Nov 17, 2026 at 10:48 AM ET

    Cocrystal Pharma Inc (COCP) Earnings: Report Dates and Results

    Updated Aug 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Cocrystal Pharma (COCP) is expected to report earnings on Mar 29, 2027. In the quarter ended Jun 30, 2026, Cocrystal Pharma reported EPS of -$0.23, below the -$0.17 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    70%(23/33)
    Avg Surprise
    +25.11%

    Upcoming Estimates

    Reports Mar 29, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.15
    RangeN/A
    5 analysts
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts

    Next Report

    COCP has an expected report date of Mar 29, 2027.

    Earnings History

    Of the 33 quarters below that had an estimate, COCP beat 23, missed 8 and matched 2. The widest gap in the table came in the quarter ended Dec 31, 2018, when EPS landed 525.00% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Jun 30, 2026-$0.23-$0.17-$0.18 - -$0.15-35.29%MissN/A20 up, 0 downAug 13, 2026$105000
    Mar 31, 2026-$0.17-$0.15-$0.16 - -$0.14-13.33%MissN/A20 up, 0 downMay 15, 2026$225000
    Dec 31, 2025-$0.17-$0.18-$0.18 - -$0.17+2.86%BeatN/A22 up, 0 downDec 31, 2025N/A
    Sep 30, 2025-$0.19-$0.21-$0.22 - -$0.21+9.52%BeatN/A21 up, 0 downNov 14, 2025N/A
    Jun 30, 2025-$0.20-$0.30-$0.44 - -$0.20+33.33%BeatN/A30 up, 0 downAug 14, 2025N/A
    Mar 31, 2025-$0.23-$0.52-$0.60 - -$0.41+55.77%BeatN/A20 up, 0 downMay 15, 2025N/A
    Dec 31, 2024-$0.32-$0.53-$0.62 - -$0.47+39.62%BeatN/A31 up, 0 downMar 31, 2025$136000
    Sep 30, 2024-$0.49-$0.57-$0.59 - -$0.55+14.04%BeatN/A30 up, 0 downNov 13, 2024N/A
    Jun 30, 2024-$0.53-$0.48-$0.56 - -$0.42-10.42%MissN/A30 up, 0 downAug 14, 2024N/A
    Mar 31, 2024-$0.39-$0.56-$0.56 - -$0.52+30.36%BeatN/A20 up, 0 downMay 13, 2024N/A
    Dec 31, 2023-$0.44-$0.60-$0.66 - -$0.55+26.67%BeatN/A30 up, 0 downMar 28, 2024$144000
    Sep 30, 2023-$0.41-$0.65-$0.65 - -$0.45+36.92%BeatN/A30 up, 0 downNov 13, 2023N/A
    Jun 30, 2023-$0.50-$0.47-$0.69 - -$0.47-6.38%MissN/A30 up, 0 downAug 14, 2023N/A
    Mar 31, 2023-$0.64-$0.70N/A+8.57%BeatN/A20 up, 0 downMay 15, 2023N/A
    Dec 31, 2022-$0.55-$0.73-$0.74 - -$0.71+24.66%BeatN/A30 up, 0 downMar 29, 2023N/A
    Sep 30, 2022-$0.70-$0.49N/A-42.86%MissN/A30 up, 0 downNov 14, 2022N/A
    Jun 30, 2022-$0.46-$0.52-$0.60 - -$0.48+11.54%BeatN/A30 up, 0 downAug 15, 2022N/A
    Mar 31, 2022-$0.48-$0.42-$0.48 - -$0.36-14.29%MissN/A20 up, 0 downMay 11, 2022N/A
    Dec 31, 2021-$0.48-$0.48-$0.48 - -$0.480.00%In lineN/A30 up, 0 downMar 23, 2022$5427
    Sep 30, 2021-$0.48-$0.48-$0.48 - -$0.360.00%In lineN/A2N/ANov 15, 2021N/A
    Jun 30, 2021-$0.48-$0.42-$0.48 - -$0.36-14.29%MissN/A2N/AAug 16, 2021N/A
    Mar 31, 2021-$0.48-$0.54-$0.60 - -$0.48+11.11%BeatN/A2N/AMay 17, 2021N/A
    Dec 31, 2020-$0.24-$0.48-$0.48 - -$0.48+50.00%BeatN/A1N/AMar 17, 2021$510000
    Sep 30, 2020-$0.57-$0.60-$0.60 - -$0.60+5.00%BeatN/A1N/ANov 16, 2020$489000
    Jun 30, 2020-$0.79-$0.48-$0.48 - -$0.48-64.58%MissN/A1N/AAug 6, 2020$554000
    Mar 31, 2020-$0.57-$0.96-$0.96 - -$0.96+40.63%BeatN/A1N/AMay 14, 2020$461000
    Dec 31, 2019-$0.60-$0.84-$0.84 - -$0.84+28.57%Beat-276.5%1N/AMar 27, 2020$402000
    Sep 30, 2019-$0.87-$0.96-$0.96 - -$0.96+9.38%BeatN/A1N/ANov 12, 2019$492000
    Jun 30, 2019-$0.81-$0.84-$0.84 - -$0.84+3.57%BeatN/A1N/AAug 9, 2019$592000
    Mar 31, 2019-$0.87-$0.96-$0.96 - -$0.96+9.38%BeatN/A1N/AApr 1, 2019$5.08M
    Dec 31, 2018$0.34-$0.08N/A+525.00%Beat+61.9%N/AN/ADec 31, 2018N/A
    Sep 30, 2018-$0.72-$0.96N/A+25.00%BeatN/AN/AN/ANov 12, 2018N/A
    Jun 30, 2018-$0.60-$0.84N/A+28.57%BeatN/AN/AN/AAug 9, 2018N/A
    Mar 31, 2018-$0.06N/AN/AN/AN/AN/AN/AN/AMay 11, 2018N/A
    Dec 31, 2017$0.21N/AN/AN/AN/AN/AN/AN/AMar 21, 2018N/A
    Sep 30, 2017-$0.09N/AN/AN/AN/AN/AN/AN/ANov 8, 2017N/A
    Jun 30, 2017-$0.04N/AN/AN/AN/AN/AN/AN/AAug 8, 2017N/A
    Mar 31, 2017-$0.11N/AN/AN/AN/AN/AN/AN/AApr 27, 2017N/A
    Dec 31, 2016-$33.15N/AN/AN/AN/AN/AN/AN/ADec 31, 2016N/A
    Sep 30, 2016-$0.96N/AN/AN/AN/AN/AN/AN/ANov 9, 2016N/A
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.79, after -$1.73 the year before. It was -$37.83 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.79N/A
    Dec 31, 2024-$1.73N/A
    Dec 31, 2023-$1.99N/A
    Dec 31, 2022-$2.19N/A
    Dec 31, 2021-$1.92N/A
    Dec 31, 2020-$2.17N/A
    Dec 31, 2019-$3.15N/A
    Dec 31, 2018-$1.04N/A
    Dec 31, 2017-$0.03N/A
    Dec 31, 2016-$37.83N/A

    Frequently Asked Questions About COCP

    When is Cocrystal Pharma's next earnings date?

    Cocrystal Pharma's next earnings report is expected for Mar 29, 2027.

    Did COCP beat earnings estimates last quarter?

    No. Cocrystal Pharma reported EPS of -$0.23 for the quarter ended Jun 30, 2026, below the -$0.17 estimate by 35.29%.

    What EPS do analysts expect from COCP next quarter?

    The consensus EPS estimate for Cocrystal Pharma for the quarter ending Dec 31, 2026 is -$0.15 from 5 analysts.

    How often does COCP beat earnings estimates?

    Cocrystal Pharma beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +13.31%.